BRIEF published on 01/24/2025 at 12:35, 1 year 8 months ago Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE published on 01/24/2025 at 12:30, 1 year 8 months ago Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF published on 01/17/2025 at 22:33, 1 year 8 months ago Moderna fait progresser le développement d'un vaccin antigrippal à base d'ARNm Essais Cliniques Vaccins À ARNm Moderne Grippe Financement BARDA
BRIEF published on 01/17/2025 at 22:33, 1 year 8 months ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 1 year 8 months ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 1 year 8 months ago Moderna présente ses orientations stratégiques lors de la conférence JP Morgan Healthcare Approbations De Vaccins Finances Moderna Prévisions De Revenus Pour 2025 Plan De Réduction Des Coûts Étapes Clés Du Pipeline
BRIEF published on 01/13/2025 at 13:05, 1 year 8 months ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE published on 01/13/2025 at 13:00, 1 year 8 months ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year 10 months ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF published on 11/25/2024 at 13:05, 1 year 10 months ago Moderna présentera ses résultats financiers lors des conférences d'investisseurs de décembre 2024 Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
Published on 10/01/2026 at 19:05, 2 hours 18 minutes ago PEL 90 Participating Interest Exchange with Chevron
Published on 10/01/2026 at 18:05, 3 hours 18 minutes ago Bocana Resources Corp. Provides a Corporate Update on Various Projects Currently Underway
Published on 10/01/2026 at 15:28, 5 hours 55 minutes ago Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement
Published on 10/01/2026 at 14:30, 6 hours 53 minutes ago Rio Grande Resources Secures Historical North Star and Little Wonder Mines and Confirms Mineralization With Returned Samples of Up to 35.9 g/t Gold and 248 g/t Silver
Published on 10/01/2026 at 14:30, 6 hours 53 minutes ago Hillcrest Energy Technologies to Present at the 2026 Cantech Investment Conference
Published on 10/01/2026 at 20:45, 37 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 52 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 2 hours 27 minutes ago Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 18:35, 2 hours 47 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 10/01/2026 at 19:00, 2 hours 23 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 2 hours 23 minutes ago AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 2 hours 42 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 2 hours 42 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 3 hours 16 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
